glp 1 and anesthesia risk Holding GLP-1 Agonists Prior to Elective Procedures New Study Recommends Stopping GLP-1

In healthy individuals, GIP(3-30)NH 2 infusions inhibit GIP-potentiated glucose-stimulated insulin secretion (75), thereby confirming GIPs role as a potent incretin hormone (87)

Nausea and vomiting (common when starting the medication but usually temporary) Diarrhea or constipation Mild fatigue or dizziness Loss of muscle mass if weight loss is too rapid A study published in JAMA found that GLP-1s significantly reduce body weight and A1C levels (a marker of blood sugar control) in older adults

H tr duy tr ln da ti tr Khi stress oxy ha c kim sot tt hn, ln da c xu hng duy tr ti sng, mm mi v u mu hn

Conclusion GLP-1 agonists like Ozempic are making waves for their ability to help with weight loss and diabetes management, but they come with some challenging side effectsespecially when it comes to your oral health